{"entity":{"id":"nct06385990","kind":"trial","name":"Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy","aka":[],"tldr":"A phase 2 trial of utidelone in triple-negative breast cancer, run by Hunan Cancer Hospital, now recruiting.","summary":"Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy is a phase 2, interventional study registered as NCT06385990 by Hunan Cancer Hospital, with a registry enrolment figure of 53 participants, started 2024-03-29 and due to reach its primary completion in 2025-03-29. Interventions recorded: UTD1. Conditions listed: Triple Negative Breast Neoplasms. Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06385990","url":"https://clinicaltrials.gov/study/NCT06385990"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-early"],"sections":[],"technologies":["cytotoxic-chemotherapy"],"targets":[],"drugs":["utidelone"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06385990","phase":"2","setting":"Clinical Study of the Efficacy and Safety of Utidelone (UTD1) Combined With Capecitabine as Adjuvant Therapy in Non-pCR Triple-negative Breast Cancer Patients After Neoadjuvant Therapy","sponsor":"Hunan Cancer Hospital","participation":[{"nct":"NCT06385990","source":"https://clinicaltrials.gov/study/NCT06385990","fetchedAt":"2026-10-07T16:54:36.402Z","studySha256":"690ef16c1aba61233acafab50e2467112d41f54b33ad83b78b2846c55bfeff40","overallStatus":"RECRUITING","lastUpdatePosted":"2024-04-26","leadSponsor":"Hunan Cancer Hospital","collaboratorCount":0,"minimumAge":"18 Years","maximumAge":"70 Years","sex":"FEMALE","healthyVolunteers":false,"hasEligibility":true,"enrolment":53,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":1,"countries":["China"]}],"started":"2024-03-29","startedType":"actual","enrolled":53,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06385990/","neighbours":{"cancer":[{"id":"tnbc-early","kind":"cancer","name":"Early triple-negative breast cancer","route":"/cancers/tnbc-early/"}],"technology":[{"id":"cytotoxic-chemotherapy","kind":"technology","name":"Cytotoxic chemotherapy","route":"/technologies/cytotoxic-chemotherapy/"}],"drug":[{"id":"utidelone","kind":"drug","name":"Utidelone","route":"/drugs/utidelone/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}